Dr. David Cohen, MD

NPI: 1649205790
Total Payments
$6,316
2024 Payments
$1,868
Companies
37
Transactions
314
Medicare Patients
3,399
Medicare Billing
$384,846

Payment Breakdown by Category

Food & Beverage$6,316 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,316 314 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,617 96 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $816.83 40 $0 (2024)
Janssen Biotech, Inc. $463.09 21 $0 (2024)
QOL Medical, LLC $434.64 14 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $259.38 14 $0 (2024)
PFIZER INC. $205.80 11 $0 (2024)
IRONWOOD PHARMACEUTICALS, INC $202.01 10 $0 (2024)
Lilly USA, LLC $188.50 6 $0 (2024)
Celgene Corporation $184.54 7 $0 (2024)
GENZYME CORPORATION $166.87 3 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,868 82 ABBVIE INC. ($571.40)
2023 $1,046 45 AbbVie Inc. ($246.46)
2022 $255.90 9 GENZYME CORPORATION ($104.60)
2021 $11.62 1 AbbVie Inc. ($11.62)
2020 $472.90 25 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($99.30)
2019 $853.81 45 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($202.07)
2018 $858.82 53 AbbVie, Inc. ($216.37)
2017 $949.30 54 AbbVie, Inc. ($266.61)

All Payment Transactions

314 individual payment records from CMS Open Payments — Page 1 of 13

Date Company Product Nature Form Amount Type
12/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $22.13 General
Category: Gastroenterology
12/19/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $16.18 General
Category: GASTROENTEROLOGY
12/18/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $41.23 General
Category: THERAPY FOR CSID
12/17/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $17.06 General
Category: IMMUNOLOGY
12/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.96 General
Category: Gastroenterology
12/03/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $11.66 General
Category: IMMUNOLOGY
11/27/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $24.04 General
Category: Immunology
11/27/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.82 General
Category: Gastroenterology
11/26/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $21.24 General
Category: IMMUNOLOGY
11/19/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $21.69 General
Category: IMMUNOLOGY
11/13/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $23.44 General
Category: Immunology
11/06/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $17.75 General
10/24/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $20.22 General
Category: GASTROENTEROLOGY
10/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.47 General
Category: Gastroenterology
10/18/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $11.17 General
Category: IMMUNOLOGY
10/17/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $28.52 General
Category: Immunology
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $28.96 General
Category: INTERNAL MEDICINE
10/07/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $43.08 General
Category: THERAPY FOR CSID
10/03/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $3.29 General
Category: ENDOCRINOLOGY
10/02/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $32.07 General
Category: INFLAMMATION AND IMMUNOLOGY
09/27/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $15.24 General
Category: IMMUNOLOGY
09/26/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $23.76 General
Category: Gastroenterology
09/24/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $11.90 General
Category: IMMUNOLOGY
09/18/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $4.69 General
Category: IMMUNOLOGY
09/17/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $22.71 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 638 687 $382,028 $72,327
2022 18 919 1,000 $566,678 $115,514
2021 17 933 1,107 $536,701 $112,892
2020 17 909 1,025 $419,165 $84,114
Total Patients
3,399
Total Services
3,819
Medicare Billing
$384,846
Procedure Codes
66

All Medicare Procedures & Services

66 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 125 126 $135,450 $25,657 18.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 113 132 $44,653 $12,532 28.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 152 173 $40,005 $11,415 28.5%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 67 69 $48,645 $6,189 12.7%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 52 53 $50,880 $4,773 9.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 28 28 $13,440 $3,271 24.3%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 15 15 $12,075 $2,752 22.8%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 27 27 $9,045 $2,611 28.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 12 12 $3,700 $1,027 27.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 11 15 $2,925 $953.55 32.6%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 12 12 $8,400 $931.01 11.1%
45381 Injection beneath lining of large bowel using a flexible endoscope Facility 2023 11 12 $11,640 $157.52 1.4%
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito Facility 2023 13 13 $1,170 $56.99 4.9%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 148 149 $160,175 $30,208 18.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 186 225 $49,980 $15,506 31.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 92 104 $33,275 $10,031 30.1%
91110 Imaging of digestive tract done from the inside of the digestive tract Office 2022 11 12 $29,520 $8,071 27.3%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 48 49 $22,870 $7,716 33.7%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 35 35 $28,175 $6,605 23.4%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 64 65 $62,400 $6,441 10.3%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 65 67 $47,235 $6,440 13.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 33 33 $15,690 $4,052 25.8%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 21 21 $16,905 $3,956 23.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 39 50 $9,225 $2,890 31.3%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 21 32 $7,407 $2,636 35.6%

About Dr. David Cohen, MD

Dr. David Cohen, MD is a Internal Medicine healthcare provider based in Attleboro, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649205790.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Cohen, MD has received a total of $6,316 in payments from pharmaceutical and medical device companies, with $1,868 received in 2024. These payments were reported across 314 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,316).

As a Medicare-enrolled provider, Cohen has provided services to 3,399 Medicare beneficiaries, totaling 3,819 services with total Medicare billing of $384,846. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Attleboro, MA
  • Active Since 07/11/2006
  • Last Updated 10/26/2015
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1649205790

Products in Payments

  • XIFAXAN (Drug) $697.53
  • STELARA (Biological) $449.76
  • Humira (Biological) $443.92
  • RINVOQ (Biological) $327.73
  • SUCRAID (Drug) $301.68
  • SKYRIZI (Biological) $262.13
  • DUPIXENT (Biological) $256.53
  • VIBERZI (Drug) $205.51
  • TRULANCE (Drug) $192.14
  • OMVOH (Drug) $188.50
  • ZEPOSIA (Drug) $184.54
  • LINZESS (Drug) $158.18
  • Cimzia (Drug) $152.17
  • Sucraid (Drug) $132.96
  • Creon (Drug) $130.64
  • ENTYVIO (Biological) $128.54
  • Linzess (Drug) $127.57
  • CREON (Drug) $114.86
  • XELJANZ (Drug) $114.60
  • Entyvio (Biological) $104.86

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Attleboro